Printer-friendly versionPrinter-friendly version

Prevention of viral hepatitis in The Netherlands: Lessons learnt and the way forward

Rotterdam, The Netherlands, November 13-14, 2008

Thursday, November 13, 2008

Session 1  Opening and objectives
Chair:  S.W. Schalm, P. van Damme

  • 09.00 - 09.25
  • Welcome and opening: H.L.A. Janssen
  • Introduction of the participants
  • Introduction of the VHPB: 1056 kB (.pdf) P. Van Damme
  • Objectives of the meeting:
    • Overview of surveillance systems for infectious diseases;
    • Update of the epidemiological situation on viral hepatitis;
    • Evaluation of current prevention and control measures on viral hepatitis;
    • Discussion on possible implementation of new prevention strategies, control measures and monitoring systems.
    • Successes, problems and barriers to overcome, and the way forward
  • Review of the meeting programme
  • Pre-meeting document 291KB (.pdf)

Session 2 The health care system in The Netherlands
Chair: S. Schalm, J. Ward

09.45 – 10.05
National immunisation program and  viral hepatitis immunisation policies  1Mb (.pdf)
H. Houweling

10.05 – 10.25
National program and epidemiology of Hepatitis C  280Kb (.pdf)
H. Reesink

10.40 – 10.55 Coffee Break

Session 3 Surveillance systems in The Netherlands
Chair: J. Van Steenbergen , P. Bonanni

10.55 – 11.15
Overview of HAV, HBV, and HCV surveillance 389Kb (.pdf)
S. Hahné

11.15 – 11.35
Mortality due to chronic viral hepatitis  383Kb (.pdf)
S.W. Schalm

11.35 – 11.55
Need for chronic viral hepatitis monitoring system 1.1Mb (.pdf)
H.L.A. Janssen

12.10 – 13.40Lunch

Session 4 Epidemiology of viral hepatitis in The Netherlands
Chair: H. Zaaijer, A Zanetti

13.40 – 14.00
Epidemiology of hepatitis B in The Netherlands 848Kb (.pdf)
M.Kretzschmar

14.00 – 14.20
Epidemiology of hepatitis C in The Netherlands 384Kb (.pdf)
S. Slavenburg 

14.20 –14.40
Molecular epidemiology of HCV infection in The Netherlands  531Kb (.pdf)
T. van de Laar

14.40 – 15.00
Molecular epidemiology of HBV infection in The Netherlands 375Kb
H. Boot

15.00 – 15.15 Discussion

15.15 – 15.35 Coffee break

15.35 – 15.55
Epidemiology of hepatitis A and E in The Netherlands  1Mb(.pdf)
J. Van Steenbergen

15.55 – 16.15
Migration and viral hepatitis  686Kb (.pdf)
T. Wörmann

16.15 – 16.30 Discussion

Session 5 Prevention and control of viral hepatitis in The Netherlands
Chair: H. Zaaijer, A. Zanetti

16.30 – 16.50
Limited control of hepatitis A by decentralized vaccination strategies. 234 Kb (.pdf)
J. van Steenbergen

16.50 – 17.10
Approach to the different risk groups for HBV and/or HCVR. 478Kb (.pdf)
R. de Knegt

17.10 – 17.30
Screening of migrants. 400Kb (.pdf)
I. Veldhuijzen

17.50 – 18.00 Summary by the chairs and Close of the day

Friday, November 14, 2008

Session 6 Prevention and control of viral hepatitis in The Netherlands
Chair: C.A.B. Boucher, F. Roudot-Thoraval

09.00 – 09.20
Viral hepatitis coinfection in HIV-infected patients.
A.Hoepelman

09.20 – 09.40
Influence of treatment on control of chronic viral hepatitis
B.J.H. Richardus

09.40 – 10.00
Health care-associated viral hepatitis  275Kb (.pdf)
H. Zaaijer

10.00 – 10.20
Pregnancy and viral hepatitis 339Kb (.pdf)
G.J. Boland

10.20 – 10.40 Discussion and lessons learnt

10.40 – 11.00 Coffee break

Session 7 Vaccination programmes
Chair: N. Emiroglu, A. C. M. Kroes

11.00 – 11.20
Update on prevention and control of hepatitis B in the WHO European Region. 510Kb (.pdf)
N. Emiroglu

11.20 – 11.40
Hepatitis B vaccination in The Netherlands: Risk group approach 450Kb (.pdf)
S. Hahné

11.40 – 12.00
Hepatitis B vaccination in The Netherlands: Universal approach 475Kb (.pdf)
C. Richter

12.30 – 14.00 Lunch

Session 8 Conclusions of the meeting
Chair:  J. Hallauer, S Wiersma

14.00 – 15.00
Presentation of the VHPB meeting conclusions143Kb (.pdf)
D. FitzSimons
 
15.00 Close of the meeting

Tags: